Rapid diagnosis of active tuberculosis by detecting antibodies from lymphocyte secretions

Journal of Infectious Diseases

Volumn 188, Issue 3, 2003, Pages 364-370

  Raqib, Rubhana ^a,e   Rahman, Jubayer ^a   Kamaluddin, A K M ^b   Kamal, S M Mostafa ^b   Banu, Fauzia A ^b   Ahmed, Shakeel ^c   Rahim, Zeaur ^a   Bardhan, Pradip K ^a   Andersson, Jan ^d   Sack, David A ^a  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b National Institute of Diseases of Chest and Hospital   (Bangladesh)

^c CHITTAGONG MEDICAL COLLEGE   (Bangladesh)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BCG VACCINE; BCG VACCINE ANTIBODY; IMMUNOGLOBULIN G; TUBERCULIN; TUBERCULIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; TUBERCULOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY-PRODUCING CELLS; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; LYMPHOCYTES; MALE; MIDDLE AGED; MYCOBACTERIUM BOVIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULIN; TUBERCULOSIS;

EID: 0041656446     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/376511     Document Type: Article

References (45)

1. World Health Organization. World Health Organization report 1999. Global tuberculosis control: communicable diseases. Geneva: World Health Organization, 1999.
2. Director General of Health Services. Report on the national prevalence survey on tuberculosis in Bangladesh, 1987-88. Dhaka, Bangladesh: Ministry of Health and Family Welfare, 1989.
3. Kumaresan JA RM, Murray CJL. Tuberculosis. In: Murray CJL, Lopez AD, eds. Global health statistics: global burden of disease and injury series. Vol 2. Boston: Harvard University Press, 1996:142-7.
4. Global tuberculosis control: surveillance, planning, financing. In: World Health Organization report 2002. Geneva: World Health Organization, 2002.
5. Surveillance for multidrug resistant Mycobacterium tuberculosis 2001-2002. ICDDR,B Health and Science Bulletin. Vol 1. Dhaka, Bangladesh: ICDDR,B, 2002:6-10.
6. Ameglio F, Giannarelli D, Cordiali-Fei P, et al. Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers. Am J Clin Pathol 1994; 101:719-25.
7. Saltini C, Colizzi V. Soluble immunological markers of disease activity in tuberculosis. Eur Respir J 1999; 14:485-6.
8. Kothadia SN, Deshmukh S, Saoji AM. Evaluation of direct microscopy as a screening test in the diagnosis of pulmonary tuberculosis. Indian J Pathol Microbiol 1990; 33:68-73.
9. Pottumarthy S, Harrison AC, Wells VC. Evaluation of the tuberculin gamma interferon assay: potential to replace the Montoux skin test. J Clin Microbiol 1999; 37:3229-32.
10. Al-Hajjaj MS, Gad-el-Rab MO, Al-Orainey IO, Al-Kassimi FA. Improved sensitivity for detection of tuberculosis cases by a modified Anda-TB ELISA test. Tuber Lung Dis 1999; 79:181-5.
11. 125 in the evaluation of tuberculosis activity. Respir Med 2001; 95:666-9.
12. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17:968-75.
13. Donald PR. Childhood tuberculosis. Curr Opin Pulm Med 2000; 6:187-92.
14. Fine PE, Sterne JA, Ponnighaus JM, Rees RJ. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994; 344:1245-9.
15. Dhand R, Ganguly NK, Vaishnavi C, Gilhotra R, Malik SK. False-positive reactions with enzyme-linked immunosorbent assay of Mycobacterium tuberculosis antigens in pleural fluid. J Med Microbiol 1988; 26:241-3.
16. Wang CR, Liu MF, Chen MY, Lin TP, Cheng CS, Chuang CY. Enzyme-linked immunosorbent assay with BCG sonicate antigen for diagnostic potential of mycobacterial infection in Taiwan. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 1989; 22:97-104.
17. Aoki A, Hagiwara E, Shirai A, et al. Their titers and recognized molecules of IgG class anti-BCG antibody in sera from patients with tuberculosis [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1990; 28:729-35.
18. Banchuin N, Wongwajana S, Pumprueg U, Jearanaisilavong J. Value of an ELISA for mycobacterial antigen detection as a routine diagnostic test of pulmonary tuberculosis. Asian Pac J Allergy Immunol 1990; 8:5-11.
19. Lu CZ, Qiao J, Shen T, Link H. Early diagnosis of tuberculous meningitis by detection of anti-BCG secreting cells in cerebrospinal fluid. Lancet 1990; 336:10-3.
20. Arend SM, Andersen P, van Meijgaarden KE, Skojot RL, Subronto YW, van Dissel JT, Ottenhoff TH. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 2000; 181:1850-4.
21. Doherty ML, Cassidy JR New perspectives on bovine tuberculosis. Vet J 2002; 163:109-10.
22. Pollock JM, Andersen P. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis 1997; 175:1251-4.
23. van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000; 7:155-60.
24. Querol JM, Oltra C, Granda D, et al. Usefulness of IgG and IgM detection against antigen 60 in the diagnosis of thoracic tuberculosis [in Spanish]. An Med Interna 1993; 10:271-4.
25. Qadri SM, Smith KK. Nonspecificity of the Anda A60-tb ELISA test for serodiagnosis of mycobacterial disease. Can J Microbiol 1992; 38:804-6.
26. Maes RF. Evaluation of the avidity of IgG anti-mycobacterial antibodies in tuberculous patients serum by an A-60 immunoassay. Eur J Epidemiol 1991; 7:188-90.
27. Delacourt C, Gobin J, Gaillard JL, de Blic J, Veron M, Scheinmann P. Value of ELISA using antigen 60 for the diagnosis of tuberculosis in children. Chest 1993; 104:393-8.
28. Turneer M, Van Nerom E, Nyabenda J, Waelbroeck A, Duvivier A, Topper M. Determination of humoral immunoglobulins M and G directed against mycobacterial antigen 60 failed to diagnose primary tuberculosis and mycobacterial adenitis in children. Am J Respir Crit Care Med 1994; 150:1508-12.
29. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 69:6554-7.
30. Lyashchenko K, Colangeli R, Houde M, Al-Jahdali H, Menzies D, Gennaro ML. Heterogeneous antibody responses in tuberculosis. Infect Immun 1998; 66:3936-40.
31. Daniel TM. Immunodiagnosis of tuberculosis. In: Rom WN, Garay SM, eds. Tuberculosis. Boston: Little, Brown & Company 1996:223-31.
32. Noordhoek GT, Arend HJK, Bjune G, et al. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol 1994; 32:277-84.
33. Chang HS, Sack DA. Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes. Clin Diagn Lab Immunol 2001; 8:482-8.
34. World Health Organization. Global tuberculosis control, 1999. Document WHO/CDS/TB/2000.275. Geneva: World Health Organization, 2000.
35. Fine P. Variation in protection by BCG: implications of end for heterologous immunity. Lancet 1995; 346:1339-45.
36. Islam D, Wretlind B, Ryd M, Lindberg AA, Christensson B. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis. Infect Immun 1995; 63:2054-61.
37. Sousa AO, Wargnier A, Poinsignon Y, Simonney N, et al. Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy. Tuber Lung Dis 2000; 80:27-33.
38. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356:1099-104.
39. Johnson PD, Stuart RL, Grayson ML, et al. Tuberculin-purified protein derivative-, MPT-64- and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999; 6:934-7.
40. Lein AD, von Reyn CF, Ravn P, Horsburgh CR Jr, Alexander LN, Andersen P. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol 1999; 6:606-9.
41. Ravn P, Demissie A, Eguale T, et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 1999; 179:637-45.
42. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183:469-77.
43. Wu-Hsieh BA, Chen C-K, Chang J-H, et al. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 2001; 33:1336-40.
44. Azim T, Islam MN, Bogaerts J, et al. Prevalence of HIV and syphilis among high-risk groups in Bangladesh. AIDS 2000; 14:210-1.
45. Azim T, Bogaerts J, Yirrell DL, et al. Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes. AIDS 2002; 16:121-3.